<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Fanconi <z:hpo ids='HP_0001903'>anemia</z:hpo> is a congenital syndrome characterized by <z:mpath ids='MPATH_133'>hypoplasia</z:mpath> of bone marrow and the development of <z:hpo ids='HP_0001915'>aplastic anemia</z:hpo> in childhood, followed by <z:hpo ids='HP_0002863'>myelodysplastic syndrome</z:hpo> and <z:hpo ids='HP_0004808'>acute myelogenous leukemia</z:hpo> in later life </plain></SENT>
<SENT sid="1" pm="."><plain>We report here a patient first diagnosed with Fanconi <z:hpo ids='HP_0001903'>anemia</z:hpo> at age 10 </plain></SENT>
<SENT sid="2" pm="."><plain>Bone marrow transplantation was performed at age 23 and repeated after an episode of rejection at age 25 </plain></SENT>
<SENT sid="3" pm="."><plain>Hematologic findings returned to <z:mpath ids='MPATH_458'>normal</z:mpath>, but <z:hpo ids='HP_0011010'>chronic</z:hpo> <z:e sem="disease" ids="C0018133" disease_type="Disease or Syndrome" abbrv="GVH">graft-versus-host disease</z:e> persisted </plain></SENT>
<SENT sid="4" pm="."><plain><z:e sem="disease" ids="C0546837,C0014859" disease_type="Neoplastic Process" abbrv="">Esophageal cancer</z:e> developed at age 35 </plain></SENT>
<SENT sid="5" pm="."><plain>Invasion of the bronchus and aorta by the <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> was suspected on computed tomography </plain></SENT>
<SENT sid="6" pm="."><plain>Chemoradiotherapy was administered to down-stage the <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e>, using low-dose <z:chebi fb="2" ids="27899">cisplatin</z:chebi> and <z:chebi fb="0" ids="46345">5-fluorouracil</z:chebi> </plain></SENT>
<SENT sid="7" pm="."><plain>After two courses of chemotherapy with <z:chebi fb="2" ids="27899">cisplatin</z:chebi> (total dose, 100 mg) and <z:chebi fb="0" ids="46345">5-fluorouracil</z:chebi> (5000 mg) plus radiotherapy (30 Gy), Grade 3 <z:hpo ids='HP_0002014'>diarrhea</z:hpo> and bone marrow suppression developed, and treatment was discontinued </plain></SENT>
<SENT sid="8" pm="."><plain>After resolution of toxicity, a good response to the neoadjuvant therapy was seen on computed tomography scan, and a subtotal esophagectomy was performed which demonstrated a complete response in the resected specimen </plain></SENT>
<SENT sid="9" pm="."><plain>However, <z:e sem="disease" ids="C0153349,C0558353" disease_type="Neoplastic Process" abbrv="">tongue cancer</z:e> developed at age 40 years, and hemiglossectomy was performed </plain></SENT>
<SENT sid="10" pm="."><plain>Patients with Fanconi <z:hpo ids='HP_0001903'>anemia</z:hpo> have a high risk of developing <z:e sem="disease" ids="C0546837,C0014859" disease_type="Neoplastic Process" abbrv="">esophageal cancer</z:e> while they are still young </plain></SENT>
<SENT sid="11" pm="."><plain>Reduced doses of <z:chebi fb="0" ids="22333">alkylating agents</z:chebi> and radiotherapy are used in patients with Fanconi <z:hpo ids='HP_0001903'>anemia</z:hpo> </plain></SENT>
<SENT sid="12" pm="."><plain>However, the optimal dosage of chemoradiotherapy and the treatment strategy for <z:e sem="disease" ids="C0546837,C0014859" disease_type="Neoplastic Process" abbrv="">esophageal cancer</z:e> in patients with Fanconi <z:hpo ids='HP_0001903'>anemia</z:hpo> remain unclear, and outcomes are generally extremely poor </plain></SENT>
<SENT sid="13" pm="."><plain>In this patient, <z:e sem="disease" ids="C0546837,C0014859" disease_type="Neoplastic Process" abbrv="">esophageal cancer</z:e> associated with Fanconi <z:hpo ids='HP_0001903'>anemia</z:hpo> responded well to multidisciplinary therapy </plain></SENT>
</text></document>